Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Pf-04531083

Generic Name: Pf-04531083

Drug Type: Small Molecule

Chemical Formula: C_₁₇H_₁₆ClN_₅O_₂

CAS Number: 1079400-07-9

Unique Ingredient Identifier: 40497CY7Y3

Overview

Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.

Background

Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain

Phase 2

Terminated

Posted: 2012/01/19

Sponsor:Pfizer

ID:NCT01512160

Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin

Phase 1

Completed

Posted: 2010/05/21

Sponsor:Pfizer

ID:NCT01127906

A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.

Phase 1

Completed

Posted: 2010/05/07

Sponsor:Pfizer

ID:NCT01119235

To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications

Phase 1

Completed

Posted: 2010/04/15

Sponsor:Pfizer

ID:NCT01103739

Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects

Phase 1

Completed

Posted: 2009/11/13

Sponsor:Pfizer

ID:NCT01012310

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy